Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Diagnosing bluetongue virus in domestic ruminants: current perspectives.

Rojas JM, Rodríguez-Martín D, Martín V, Sevilla N.

Vet Med (Auckl). 2019 Feb 14;10:17-27. doi: 10.2147/VMRR.S163804. eCollection 2019. Review.

2.

Peste des Petits Ruminants Virus Fusion and Hemagglutinin Proteins Trigger Antibody-Dependent Cell-Mediated Cytotoxicity in Infected Cells.

Rojas JM, Rodríguez-Martín D, Avia M, Martín V, Sevilla N.

Front Immunol. 2019 Jan 14;9:3172. doi: 10.3389/fimmu.2018.03172. eCollection 2018.

3.

A virus-encoded type I interferon decoy receptor enables evasion of host immunity through cell-surface binding.

Hernáez B, Alonso-Lobo JM, Montanuy I, Fischer C, Sauer S, Sigal L, Sevilla N, Alcamí A.

Nat Commun. 2018 Dec 21;9(1):5440. doi: 10.1038/s41467-018-07772-z.

4.

Novel alleles of rice eIF4G generated by CRISPR/Cas9-targeted mutagenesis confer resistance to Rice tungro spherical virus.

Macovei A, Sevilla NR, Cantos C, Jonson GB, Slamet-Loedin I, Čermák T, Voytas DF, Choi IR, Chadha-Mohanty P.

Plant Biotechnol J. 2018 Nov;16(11):1918-1927. doi: 10.1111/pbi.12927. Epub 2018 Apr 30.

5.

Bovine Herpesvirus-4-Based Vector Delivering Peste des Petits Ruminants Virus Hemagglutinin ORF Induces both Neutralizing Antibodies and Cytotoxic T Cell Responses.

Macchi F, Rojas JM, Verna AE, Sevilla N, Franceschi V, Tebaldi G, Cavirani S, Martín V, Donofrio G.

Front Immunol. 2018 Mar 5;9:421. doi: 10.3389/fimmu.2018.00421. eCollection 2018.

6.
7.

Recall T cell responses to bluetongue virus produce a narrowing of the T cell repertoire.

Rojas JM, Rodríguez-Calvo T, Sevilla N.

Vet Res. 2017 Jun 29;48(1):38. doi: 10.1186/s13567-017-0444-3.

8.

IL-10: A Multifunctional Cytokine in Viral Infections.

Rojas JM, Avia M, Martín V, Sevilla N.

J Immunol Res. 2017;2017:6104054. doi: 10.1155/2017/6104054. Epub 2017 Feb 20. Review.

9.

Follicular dendritic cell disruption as a novel mechanism of virus-induced immunosuppression.

Melzi E, Caporale M, Rocchi M, Martín V, Gamino V, di Provvido A, Marruchella G, Entrican G, Sevilla N, Palmarini M.

Proc Natl Acad Sci U S A. 2016 Oct 11;113(41):E6238-E6247. Epub 2016 Sep 26.

10.

Long-term Survival after Carotid Endarterectomy in a Population with a Low Coronary Heart Disease Fatality: Implications for Decision Making.

Ruiz-Carmona C, Diaz-Duran C, Sevilla N, Cuadrado E, Clará A.

Ann Vasc Surg. 2016 Oct;36:153-158. doi: 10.1016/j.avsg.2016.01.059. Epub 2016 Jun 16.

PMID:
27321978
11.

A Recombinant Adenovirus Expressing Ovine Interferon Tau Prevents Influenza Virus-Induced Lethality in Mice.

Martín V, Pascual E, Avia M, Rangel G, de Molina A, Alejo A, Sevilla N.

J Virol. 2016 Jan 6;90(7):3783-8. doi: 10.1128/JVI.03258-15.

12.

Survival After Endovascular Abdominal Aortic Aneurysm Repair in a Population with a Low Incidence of Coronary Artery Disease.

Sevilla N, Clara A, Diaz-Duran C, Ruiz-Carmona C, Ibañez S.

World J Surg. 2016 May;40(5):1272-8. doi: 10.1007/s00268-015-3377-x.

PMID:
26711643
13.

Protective Efficacy in Sheep of Adenovirus-Vectored Vaccines against Bluetongue Virus Is Associated with Specific T Cell Responses.

Martín V, Pascual E, Avia M, Peña L, Valcárcel F, Sevilla N.

PLoS One. 2015 Nov 30;10(11):e0143273. doi: 10.1371/journal.pone.0143273. eCollection 2015.

14.

Vaccination with recombinant adenoviruses expressing the peste des petits ruminants virus F or H proteins overcomes viral immunosuppression and induces protective immunity against PPRV challenge in sheep.

Rojas JM, Moreno H, Valcárcel F, Peña L, Sevilla N, Martín V.

PLoS One. 2014 Jul 11;9(7):e101226. doi: 10.1371/journal.pone.0101226. eCollection 2014.

15.
16.

Two replication-defective adenoviral vaccine vectors for the induction of immune responses to PPRV.

Rojas JM, Moreno H, García A, Ramírez JC, Sevilla N, Martín V.

Vaccine. 2014 Jan 9;32(3):393-400. doi: 10.1016/j.vaccine.2013.11.033. Epub 2013 Nov 20.

PMID:
24269622
17.

Type I interferon limits the capacity of bluetongue virus to infect hematopoietic precursors and dendritic cells in vitro and in vivo.

Rodríguez-Calvo T, Rojas JM, Martín V, Sevilla N.

J Virol. 2014 Jan;88(2):859-67. doi: 10.1128/JVI.02697-13. Epub 2013 Oct 30.

18.

Mutagenesis-mediated decrease of pathogenicity as a feature of the mutant spectrum of a viral population.

Sanz-Ramos M, Rodríguez-Calvo T, Sevilla N.

PLoS One. 2012;7(6):e39941. doi: 10.1371/journal.pone.0039941. Epub 2012 Jun 28.

19.

T cell responses to bluetongue virus are directed against multiple and identical CD4+ and CD8+ T cell epitopes from the VP7 core protein in mouse and sheep.

Rojas JM, Rodríguez-Calvo T, Peña L, Sevilla N.

Vaccine. 2011 Sep 16;29(40):6848-57. doi: 10.1016/j.vaccine.2011.07.061. Epub 2011 Jul 30.

PMID:
21807057
20.

Ribavirin can be mutagenic for arenaviruses.

Moreno H, Gallego I, Sevilla N, de la Torre JC, Domingo E, Martín V.

J Virol. 2011 Jul;85(14):7246-55. doi: 10.1128/JVI.00614-11. Epub 2011 May 11.

21.

Evidence of activation and suppression during the early immune response to foot-and-mouth disease virus.

Golde WT, de Los Santos T, Robinson L, Grubman MJ, Sevilla N, Summerfield A, Charleston B.

Transbound Emerg Dis. 2011 Aug;58(4):283-90. doi: 10.1111/j.1865-1682.2011.01223.x. Epub 2011 Apr 18. Review.

PMID:
21501424
22.

CK12, a rainbow trout chemokine with lymphocyte chemo-attractant capacity associated to mucosal tissues.

Montero J, Ordas MC, Alejo A, Gonzalez-Torres L, Sevilla N, Tafalla C.

Mol Immunol. 2011 May;48(9-10):1102-13. doi: 10.1016/j.molimm.2011.02.005. Epub 2011 Mar 8.

PMID:
21388685
23.

A replication analysis of foot-and-mouth disease virus in swine lymphoid tissue might indicate a putative carrier stage in pigs.

Rodríguez-Calvo T, Díaz-San Segundo F, Sanz-Ramos M, Sevilla N.

Vet Res. 2011 Feb 7;42:22. doi: 10.1186/1297-9716-42-22.

24.

New vaccine design based on defective genomes that combines features of attenuated and inactivated vaccines.

Rodríguez-Calvo T, Ojosnegros S, Sanz-Ramos M, García-Arriaza J, Escarmís C, Domingo E, Sevilla N.

PLoS One. 2010 Apr 29;5(4):e10414. doi: 10.1371/journal.pone.0010414.

25.

Heterologous prime boost vaccination with DNA and recombinant modified vaccinia virus Ankara protects IFNAR(-/-) mice against lethal bluetongue infection.

Calvo-Pinilla E, Rodríguez-Calvo T, Sevilla N, Ortego J.

Vaccine. 2009 Dec 11;28(2):437-45. doi: 10.1016/j.vaccine.2009.10.027. Epub 2009 Oct 24.

PMID:
19857449
26.

Immunosuppression during acute infection with foot-and-mouth disease virus in swine is mediated by IL-10.

Díaz-San Segundo F, Rodríguez-Calvo T, de Avila A, Sevilla N.

PLoS One. 2009 May 21;4(5):e5659. doi: 10.1371/journal.pone.0005659.

27.

Arenavirus genetic diversity and its biological implications.

Emonet SF, de la Torre JC, Domingo E, Sevilla N.

Infect Genet Evol. 2009 Jul;9(4):417-29. doi: 10.1016/j.meegid.2009.03.005. Epub 2009 Mar 25. Review.

PMID:
19460307
28.

Establishment of a bluetongue virus infection model in mice that are deficient in the alpha/beta interferon receptor.

Calvo-Pinilla E, Rodríguez-Calvo T, Anguita J, Sevilla N, Ortego J.

PLoS One. 2009;4(4):e5171. doi: 10.1371/journal.pone.0005171. Epub 2009 Apr 9.

29.

Hidden virulence determinants in a viral quasispecies in vivo.

Sanz-Ramos M, Díaz-San Segundo F, Escarmís C, Domingo E, Sevilla N.

J Virol. 2008 Nov;82(21):10465-76. doi: 10.1128/JVI.00825-08. Epub 2008 Aug 20.

30.

Interleukin 8 and CK-6 chemokines specifically attract rainbow trout (Oncorhynchus mykiss) RTS11 monocyte-macrophage cells and have variable effects on their immune functions.

Montero J, Coll J, Sevilla N, Cuesta A, Bols NC, Tafalla C.

Dev Comp Immunol. 2008;32(11):1374-84. doi: 10.1016/j.dci.2008.05.004. Epub 2008 Jun 6.

PMID:
18572244
31.

Altered lymphocyte homeostasis after oral prion infection in mouse.

Segundo FD, Sevilla N, Gutiérrez JP, Brun A.

Vet Immunol Immunopathol. 2008 Apr 15;122(3-4):204-15. doi: 10.1016/j.vetimm.2007.11.013. Epub 2007 Dec 7.

PMID:
18207573
32.

Arenavirus diversity and evolution: quasispecies in vivo.

Sevilla N, de la Torre JC.

Curr Top Microbiol Immunol. 2006;299:315-35. Review.

PMID:
16568904
33.

Selective lymphocyte depletion during the early stage of the immune response to foot-and-mouth disease virus infection in swine.

Díaz-San Segundo F, Salguero FJ, de Avila A, de Marco MM, Sánchez-Martín MA, Sevilla N.

J Virol. 2006 Mar;80(5):2369-79.

34.

Predominant fusion of bone marrow-derived cardiomyocytes.

Andrade J, Lam JT, Zamora M, Huang C, Franco D, Sevilla N, Gruber PJ, Lu JT, Ruiz-Lozano P.

Cardiovasc Res. 2005 Dec 1;68(3):387-93. Epub 2005 Oct 27.

PMID:
16256964
35.

G-induced loss of consciousness: case-control study of 78 G-Locs in the F-15, F-16, and A-10.

Sevilla NL, Gardner JW.

Aviat Space Environ Med. 2005 Apr;76(4):370-4.

PMID:
15828637
36.

Foot-and-mouth disease virus (FMDV) causes an acute disease that can be lethal for adult laboratory mice.

Salguero FJ, Sánchez-Martín MA, Díaz-San Segundo F, de Avila A, Sevilla N.

Virology. 2005 Feb 5;332(1):384-96.

37.
38.

Viral targeting of hematopoietic progenitors and inhibition of DC maturation as a dual strategy for immune subversion.

Sevilla N, McGavern DB, Teng C, Kunz S, Oldstone MB.

J Clin Invest. 2004 Mar;113(5):737-45.

39.

Infection of dendritic cells by lymphocytic choriomeningitis virus.

Sevilla N, Kunz S, McGavern D, Oldstone MB.

Curr Top Microbiol Immunol. 2003;276:125-44. Review.

40.

Contribution of LCMV towards deciphering biology of quasispecies in vivo.

Sevilla N, Domingo E, de la Torre JC.

Curr Top Microbiol Immunol. 2002;263:197-220. Review. No abstract available.

PMID:
11987815
41.

Molecular analysis of the interaction of LCMV with its cellular receptor [alpha]-dystroglycan.

Kunz S, Sevilla N, McGavern DB, Campbell KP, Oldstone MB.

J Cell Biol. 2001 Oct 15;155(2):301-10. Epub 2001 Oct 15.

42.

Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells.

Sevilla N, Kunz S, Holz A, Lewicki H, Homann D, Yamada H, Campbell KP, de La Torre JC, Oldstone MB.

J Exp Med. 2000 Nov 6;192(9):1249-60.

43.

Virus-induced diabetes in a transgenic model: role of cross-reacting viruses and quantitation of effector T cells needed to cause disease.

Sevilla N, Homann D, von Herrath M, Rodriguez F, Harkins S, Whitton JL, Oldstone MB.

J Virol. 2000 Apr;74(7):3284-92.

44.

Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: flexibility in aphthovirus receptor usage.

Baranowski E, Ruiz-Jarabo CM, Sevilla N, Andreu D, Beck E, Domingo E.

J Virol. 2000 Feb;74(4):1641-7.

45.

Biochemical and structural studies with neutralizing antibodies raised against foot-and-mouth disease virus.

Domingo E, Verdaguer N, Ochoa WF, Ruiz-Jarabo CM, Sevilla N, Baranowski E, Mateu MG, Fita I.

Virus Res. 1999 Aug;62(2):169-75. Review.

PMID:
10507326
46.

Antigenic properties and population stability of a foot-and-mouth disease virus with an altered Arg-Gly-Asp receptor-recognition motif.

Ruiz-Jarabo CM, Sevilla N, Dávila M, Gómez-Mariano G, Baranowski E, Domingo E.

J Gen Virol. 1999 Aug;80 ( Pt 8):1899-909.

PMID:
10466785
47.

An RNA virus can adapt to the multiplicity of infection.

Sevilla N, Ruiz-Jarabo CM, Gómez-Mariano G, Baranowski E, Domingo E.

J Gen Virol. 1998 Dec;79 ( Pt 12):2971-80. Erratum in: J Gen Virol 1999 Apr;80(Pt 4):1087.

PMID:
9880011
48.

Population dynamics in the evolution of RNA viruses.

Domingo E, Escarmís C, Sevilla N, Baranowski E.

Adv Exp Med Biol. 1998;440:721-7. Review.

PMID:
9782350
49.

Multiple virulence determinants of foot-and-mouth disease virus in cell culture.

Baranowski E, Sevilla N, Verdaguer N, Ruiz-Jarabo CM, Beck E, Domingo E.

J Virol. 1998 Aug;72(8):6362-72.

50.

A similar pattern of interaction for different antibodies with a major antigenic site of foot-and-mouth disease virus: implications for intratypic antigenic variation.

Verdaguer N, Sevilla N, Valero ML, Stuart D, Brocchi E, Andreu D, Giralt E, Domingo E, Mateu MG, Fita I.

J Virol. 1998 Jan;72(1):739-48.

Supplemental Content

Loading ...
Support Center